Leading the charge in malaria: Professor Brendan Crabb AC wins GSK Award for Research Excellence
Home
Our News
GSK Australia now holds the marketing authorisation for Zejula (niraparib) for ovarian cancer
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
Bushfire crisis response from GSK Australia
Australian researcher uncovering keys to malaria elimination receives major research award
GSK Australia launches Spectrum: resource group for LGBT+ employees and straight allies
Tweets from GSK Australia
-
We’re donating $10 million to The COVID-19 Solidarity Response Fund, created by the @unfoundation and @WHO, to help… twitter.com/i/web/status/1…
3 days ago
-
@FoJenot @FoJenot Thanks for getting in touch. At this time, ViiV Healthcare Aus has adequate stock in place, and w… twitter.com/i/web/status/1…
last week
-
Let’s turn the leadership pyramid upside down, listen to our teams and have open conversations about creating a sup… twitter.com/i/web/status/1…
3 weeks ago
